AI-driven drug discovery and repurposing using multi-omics for myocardial infarction and heart failure
Cardiovascular diseases (CVDs) are the leading causes of morbidity and mortality worldwide. Yet, drug discovery for these conditions faces significant challenges due to the complexity and heterogeneity of their underlying pathology. Recently, artificial intelligence (AI) techniques—particularly expl...
Saved in:
| Main Authors: | Ziad Sabry, Harkirat Singh Arora, Sriram Chandrasekaran, Zhong Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Open Exploration Publishing Inc.
2025-06-01
|
| Series: | Exploration of Medicine |
| Subjects: | |
| Online Access: | https://www.explorationpub.com/uploads/Article/A1001340/1001340.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery of novel antifungal drugs via screening repurposing libraries against Coccidioides posadasii spherule initials
by: Sarah Saeger, et al.
Published: (2025-05-01) -
DTA Atlas: A massive-scale drug repurposing database
by: Madina Sultanova, et al.
Published: (2024-12-01) -
EXPLORING THE ROLE OF DRUGBANK IN INVESTIGATING PHARMACOGENOMIC-DRIVEN NOVEL DRUG
by: Setiyo Budi Santoso, et al.
Published: (2025-07-01) -
Harnessing Artificial Intelligence in Drug Discovery: Transformative Approaches and Future Directions
by: Damini Dilip Salunke, et al.
Published: (2025-05-01) -
VARIANTS AND PERSPECTIVES OF DRUG REPURPOSING FOR CANCER TREATMENT
by: A. V. Savinkova, et al.
Published: (2018-07-01)